网站主页 >> CAS数据库列表 >> (2R)-2-[[6-[(3-氯-4-羧基苯基)氨基]-9-(1-甲基乙基)-9H-嘌呤-2-基]氨基]-3-甲基-1-丁醇
(2R)-2-[[6-[(3-氯-4-羧基苯基)氨基]-9-(1-甲基乙基)-9H-嘌呤-2-基]氨基]-3-甲基-1-丁醇
|
|
- CAS号:
- 212844-54-7
- 英文名:
- (2R)-2-[[6-[(3-CHLORO-4-CARBOXYPHENYL)AMINO]-9-(1-METHYLETHYL)-9H-PURIN-2-YL]AMINO]-3-METHYL-1-BUTANOL
- 英文别名:
- NG 95;CS-2003;PURVALANOL B;NG 95; NG95; NG-95;Purvalanol B, >=96%;Purvalanol B(NG 95);(R)-2-Chloro-4-((2-((1-hydroxy-3-methylbutan-2-yl)amino)-9-isopropyl-9H-purin-6-yl)amino)benzo;(R)-2-CHLORO-4-(2-(1-HYDROXY-3-METHYLBUTAN-2-YLAMINO)-9-ISOPROPYL-9H-PURIN-6-YLAMINO)BENZOIC ACID;(2R)-2-((6-((3-Chloro-4-carboxyphenyl)amino)-9-(1-methylethyl)-9H-purin-2-yl)amino)-3-methyl-1-butanol;(2R)-2-[[6-[(3-CHLORO-4-CARBOXYPHENYL)AMINO]-9-(1-METHYLETHYL)-9H-PURIN-2-YL]AMINO]-3-METHYL-1-BUTANOL
- 中文名:
- (2R)-2-[[6-[(3-氯-4-羧基苯基)氨基]-9-(1-甲基乙基)-9H-嘌呤-2-基]氨基]-3-甲基-1-丁醇
- 中文别名:
- 化合物 PURVALANOL B;CDK抑制剂(PURVALANOL B);PURVALANOL B,CDK2抑制剂;(R)-2-氯-4-((2-((1-羟基-3-甲基丁-2-基)氨基)-9-异丙基-9H-嘌呤-6-基)氨基)苯甲酸;(2R)-2-[[6-[(3-氯-4-羧基苯基)氨基]-9-(1-甲基乙基)-9H-嘌呤-2-基]氨基]-3-甲基-1-丁醇;(2R)-2-[[6-[(3-氯-4-羧基苯基)氨基]-9-(1-甲基乙基)-9H-嘌呤-2-基]氨基]-3-甲基-1-丁醇(PURVALANOL B(NG 95) )
- CBNumber:
- CB1100440
- 分子式:
- C20H25ClN6O3
- 分子量:
- 432.9
- MOL File:
- 212844-54-7.mol
|
|
|
(2R)-2-[[6-[(3-氯-4-羧基苯基)氨基]-9-(1-甲基乙基)-9H-嘌呤-2-基]氨基]-3-甲基-1-丁醇化学性质
-
熔点:
-
58.5 °C
-
|
-
沸点:
-
660.6±65.0 °C(Predicted)
-
|
-
密度:
-
1.43±0.1 g/cm3(Predicted)
-
|
-
储存条件:
-
Keep in dark place,Sealed in dry,Store in freezer, under -20°C
-
|
-
溶解度:
-
DMSO: 37 mg/mL, soluble
-
|
-
形态:
-
solid
-
|
-
酸度系数(pKa):
-
2.81±0.25(Predicted)
-
|
-
颜色:
-
White to light yellow
-
|
-
InChIKey:
-
ZKDXRFMOHZVXSG-HNNXBMFYSA-N
-
|
(2R)-2-[[6-[(3-氯-4-羧基苯基)氨基]-9-(1-甲基乙基)-9H-嘌呤-2-基]氨基]-3-甲基-1-丁醇性质、用途与生产工艺
Purvalanol B (NG-95) 是一种有效的、选择性的 cyclin-dependent kinase (CDK) 的抑制剂,其对cdc2-cyclin B、CDK2-cyclin A、CDK2-cyclin E和CDK5-p35的IC50值分别为6 nM、6 nM、9 nM和6 nM。
Target | Value |
cdc2-cyclin B
(Cell-free assay)
|
6 nM
|
CDK2-Cyclin A
(Cell-free assay)
|
6 nM
|
CDK5-P35
(Cell-free assay)
|
6 nM
|
CDK2-Cyclin E
(Cell-free assay)
|
9 nM
|
(2R)-2-[[6-[(3-氯-4-羧基苯基)氨基]-9-(1-甲基乙基)-9H-嘌呤-2-基]氨基]-3-甲基-1-丁醇
上下游产品信息
上游原料
下游产品
更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
---|
2024/08/19 | HY-18299 | (2R)-2-[[6-[(3-氯-4-羧基苯基)氨基]-9-(1-甲基乙基)-9H-嘌呤-2-基]氨基]-3-甲基-1-丁醇 Purvalanol B | 212844-54-7 | 5mg | 740元 |
2024/08/19 | HY-18299 | (2R)-2-[[6-[(3-氯-4-羧基苯基)氨基]-9-(1-甲基乙基)-9H-嘌呤-2-基]氨基]-3-甲基-1-丁醇 Purvalanol B | 212844-54-7 | 10mM * 1mLin DMSO | 820元 |
(2R)-2-[[6-[(3-氯-4-羧基苯基)氨基]-9-(1-甲基乙基)-9H-嘌呤-2-基]氨基]-3-甲基-1-丁醇
生产厂家
212844-54-7, (2R)-2-[[6-[(3-氯-4-羧基苯基)氨基]-9-(1-甲基乙基)-9H-嘌呤-2-基]氨基]-3-甲基-1-丁醇 相关搜索:
- Signalling
- 抑制剂
- 合成有机化合物配体
- 细胞生物学试剂
- BioChemical
- Cell Biology
- Cell Signaling and Neuroscience
- Kinase/Phosphatase Biology
- Serine/Threonine Kinase Inhibitors
- Cyclin-Dependent Kinase (CDK)
- C20H25ClN6O3
- 化合物 PURVALANOL B
- PURVALANOL B,CDK2抑制剂
- (R)-2-氯-4-((2-((1-羟基-3-甲基丁-2-基)氨基)-9-异丙基-9H-嘌呤-6-基)氨基)苯甲酸
- CDK抑制剂(PURVALANOL B)
- (2R)-2-[[6-[(3-氯-4-羧基苯基)氨基]-9-(1-甲基乙基)-9H-嘌呤-2-基]氨基]-3-甲基-1-丁醇(PURVALANOL B(NG 95) )
- (2R)-2-[[6-[(3-氯-4-羧基苯基)氨基]-9-(1-甲基乙基)-9H-嘌呤-2-基]氨基]-3-甲基-1-丁醇
- 212844-54-7
- Benzoic acid, 2-chloro-4-[[2-[[(1R)-1-(hydroxymethyl)-2-methylpropyl]amino]-9-(1-methylethyl)-9H-purin-6-yl]amino]-
- NG 95; NG95; NG-95
- CS-2003
- (R)-2-CHLORO-4-(2-(1-HYDROXY-3-METHYLBUTAN-2-YLAMINO)-9-ISOPROPYL-9H-PURIN-6-YLAMINO)BENZOIC ACID
- Purvalanol B(NG 95)
- (R)-2-Chloro-4-((2-((1-hydroxy-3-methylbutan-2-yl)amino)-9-isopropyl-9H-purin-6-yl)amino)benzo
- Purvalanol B, >=96%
- NG 95, (2R)-2-[[6-[(3-Chloro-4-carboxyphenyl)amino]-9-(1-methylethyl)-9H-purin-2-yl]amino]-3-methyl-1-butanol
- (2R)-2-((6-((3-Chloro-4-carboxyphenyl)amino)-9-(1-methylethyl)-9H-purin-2-yl)amino)-3-methyl-1-butanol
- NG 95
- PURVALANOL B
- (2R)-2-[[6-[(3-CHLORO-4-CARBOXYPHENYL)AMINO]-9-(1-METHYLETHYL)-9H-PURIN-2-YL]AMINO]-3-METHYL-1-BUTANOL